Neobe Raises $6.8 Million to Send Engineered Bacteria Into Solid Tumors
Neobe Therapeutics raised $6.8 million in seed funding led by ARC Ventures, bringing total funding past $10.5 million as it advances engineered bacteria toward a 2028 IND filing.
